Podcasts about bioverativ

Elisabeth (Elise) C. Terlato has worked in the wine industry for five years now, joining the family's company in October of 2018 as the Associate Marketing Manager. In this role, she was responsible for marketing and managing Terlato Wines International's Estate Division portfolio of brands, including Terlato Vineyards, M. Chapoutier, Mathilde Chapoutier, Domaine Terlato & Chapoutier, and Anselmi. Elise is the fourth generation to be involved in the family business, along with her sister, Jo, and brother, Tony. In 2020, Elise was promoted to Digital Marketing Manager, responsible for managing and growing the DTC business through e-commerce, social media, and various other digital platforms. In 2021, she spearheaded and managed two large-scale projects: the renovation and launch of Terlato.com and the Uncorked.com websites. In 2022, Elise advanced to Marketing Manager for Terlato's Direct-to-Consumer (DTC) side of the business. In this role, she is responsible for all direct marketing from family wineries, which includes increasing, creating, and analyzing promotions and programs to drive the Terlato Wine Group's (TWG) e-commerce business, assisting in all electronic and physical communications (including newsletters and websites), managing and executing content, driving business to websites, and managing all loyalty and club programming. Prior to joining Terlato, Elise worked at Foote, Cone & Belding (FCB) Global Chicago for three and a half years, where she progressed from an Assistant Account Executive to Account Executive. At FCB, she managed clients such as Choose Chicago, Bioverativ, and Johnson & Johnson. Additionally, she produced advertisements for high-profile brands such as Mazzoni and Adelphi scotch whisky, which were published in national beverage publications including Wine Spectator, Wine & Spirits, and The Tasting Panel. Elise also has experience working at Modern Luxury Publications in their marketing department. During her internships at the Il Poggione and GAJA wineries in the Tuscan and Piedmont regions of Italy, Elise studied the retail and production sides of the wine industry. She holds a bachelor's degree from Florida's University of Miami and is continuing her wine education with a WSET II (Wine & Spirits Education Trust) certificate and diploma in Wine Management and Gastronomy from Le Cordon Bleu in London. In this episode… For more than 50 years, Terlato Wines International has been influential in the wine and spirits industry. They introduced Pinot Grigio to America, revolutionized different varietals, and became a well-loved legacy brand. But they've never stopped looking for the next best thing for consumers across the globe, which is why they've grown year after year.  According to Elise Terlato, much of the brand's success comes from the ability to adapt, utilize cutting-edge technologies, and meet the consumer where they are. The digital world will only continue to expand, so it's crucial that wineries — including legacy brands — learn how to navigate this space and build their online presence. So if you're a brand that wants to embrace digital and reach a wider audience, what does Elise recommend?  In this episode of VINTed, Scout Driscoll is in conversation with Elise Terlato, DTC Marketing Manager at Terlato Wines International, to talk about legacy brands, marketing to the modern consumer, and getting involved in the digital world. Elise shares how Terlato is elevating and partnering with other brands, their strategies for connecting with younger consumers, and their mission to promote sustainability through their wineries and vineyards. 

This KGI Industry Talk features Ravneesh Sachdev, the Vice President and Head of Business Development at Sage Therapeutics, based in Cambridge, MA. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, including Zulresso™, the first FDA-approved drug specifically for postpartum depression. Ravneesh evaluates and transacts on partnerships in order to inorganically grow Sage’s business. Over the past 15+ years of his business development career, Ravneesh has contributed to, as well as led, the execution of more than 20 partnerships during his tenure at several other companies, namely Pfizer, Onyx Pharmaceuticals (now part of Amgen), UCB Pharma, Acorda Therapeutics, and Bioverativ (now part of Sanofi). Ravneesh earned his bachelor’s degree in Molecular Neuroscience from Claremont McKenna College, his Master of Business and Science degree from KGI, and his MBA in Healthcare Leadership from Yale University School of Management. 

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sanofi, Bioverativ, Ablynx, AstraZeneca, Abbvie, EMA, Gilead, Precision BioSciences, Janssen, Arog Pharmaceuticals, PPD, ProClinical.Persone: Giulia Gargiulo (AstraZeneca), Guido Rasi (EMA), Fabio Conforti (IEO di Milano), Sergio Mattarella (Presidente della Repubblica).Nuove terapie: ustekinumab.Patologie: cancro, epatite B, ipertensione arteriosa, Parkinson, morbo di Chron.Lavoro: Clinical Research Associate.Il mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sanofi, Bioverativ, Ablynx, AstraZeneca, Abbvie, EMA, Gilead, Precision BioSciences, Janssen, Arog Pharmaceuticals, PPD, ProClinical.Persone: Giulia Gargiulo (AstraZeneca), Guido Rasi (EMA), Fabio Conforti (IEO di Milano), Sergio Mattarella (Presidente della Repubblica).Nuove terapie: ustekinumab.Patologie: cancro, epatite B, ipertensione arteriosa, Parkinson, morbo di Chron.Lavoro: Clinical Research Associate.Il mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

This month on BloodStream, we review major takeaways from World Federation of Hemophilia’s 2018 World Congress, Dakota Rosenfelt shares his journey of life with hemophilia, and we speak with Lisa Thibeault, the nurse coordinator from the Southeastern Ontario Regional Inherited Bleeding Disorders Program in Ontario, Canada, about the progress made in the treatment of women with bleeding disorders. All that and more on Episode 25 of The BloodStream Podcast! Exclusive Sponsor: Shire World Federation of Hemophilia 2018 World Congress World Congress Daily Recaps FDA Clears way for gene therapy BioMarin presents data on BMN 270 Bayer presents insights on HemACTIVE study Novo Nordisk presents data on Rebinyn and presents study data on NovoEight CSL Behring Supports patient advocacy groups through LEAD Program Octapharma presents data on SubQ-8 and presents data on Nuwiq UniQure presents data their AAV5 gene therapy program Bioverativ (a Sanofi company) presents preliminary data for BIVV001 Shire presents data on rVWF in the treatment of people with VWD National Hemophilia Foundation’s Dawn Rotellini elected to WFH’s Board of Directors. Genentech/Roche received Priority Review from the FDA for Hemlibra in Hem A patients without inhibitors. coreHEM publishes Core Outcome Set for Hemophilia Clinical Trials Spark and Pfizer present data on SPK-9001 and the modified process New study looks at Von Willebrand Disease, Von Willebrand Factor, and Aging   Latest Ask The Expert Podcast: Episode 15 featuring Shari Luckey.  Latest Powering Through Podcast: Episode 17 featuring Vanessa Flora, Jason Flora, and Heather Stephenson Share Segment: Dakota Rosenfelt - A Prescription for Success Interview Segment: Lisa Thibeault, RN - Let’s Talk Period, from Queen’s University + partners   BloodFeed: https://www.bloodfeed.com Connect with BloodStream: Email mailbag@bloodstreammedia.com Find all of our bleeding disorders podcasts on BloodStreamMedia.com BloodStream Facebook Page BloodStream Twitter Account Subscribe to BloodStream: iTunes: http://bit.ly/bloodstreamitunes Stitcher: http://bit.ly/bloodstreamstitcher LibSyn: http://bit.ly/bloodstreamlibsyn SoundCloud: http://bit.ly/bloodstreamSC TuneIn: http://bit.ly/bloodstreamtunein Google Play: http://bit.ly/bloodstreamPlay Spotify: http://spoti.fi/2nNPhui

Today in FirstWord:

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Gsk, Johnson & Johnson, Sanofi, Bioverativ, Celgene, Juno Therapeutics, EMA, Dompè, Roche, Boehringer Ingelheim.Persone: Tamara Rogers (GSK), Rita Levi Montalcini.Nuove terapie: Cenegermin, emicizumab.Patologie: cancro, emofilia, cheratite neurotrofica.Lavoro: Medical Scientific Liaison, Clinical Site Manager.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Gsk, Johnson & Johnson, Sanofi, Bioverativ, Celgene, Juno Therapeutics, EMA, Dompè, Roche, Boehringer Ingelheim.Persone: Tamara Rogers (GSK), Rita Levi Montalcini.Nuove terapie: Cenegermin, emicizumab.Patologie: cancro, emofilia, cheratite neurotrofica.Lavoro: Medical Scientific Liaison, Clinical Site Manager.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

In this episode, Dr. Steven Pipe, a pediatric hematologist out of the University of Michigan who is also the chair of the National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC) discusses the major takeaways from the International Society of Thrombosis and Hemostasis’ (ISTH) 2017 Congress, which took place this July in Berlin, Germany. Dr. Pipe shares the latest updates on non-factor replacement therapies, gene therapy, and more on Episode 5 of BloodStream Media’s Ask The Expert podcast series! Disclaimer: The content contained within Ask The Expert is for informational purposes only. Please consult your healthcare provider before making any decisions about treatment. Have a bleeding disorders-related question you’d like to submit to Ask The Expert? Excellent! You can email it to mailbag@bloodstreammedia.com (Subject: Ask The Expert Question), post it on the wall of our Facebook Page, Facebook.com/BloodStreamMedia or tweet it to us @BloodStreamInfo or @pjlynch (host)   ISTH Congress 2017 Headlines: BioMarin and Spark: http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/ Idelvion: https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/ Emicizumab: https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors Nuwiq: http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE Q&A with R&D chief of Bioverativ: https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline Steven Pipe presents small molecule therapies: http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/  

On this episode, Dr. Steven Pipe- pediatric hematologist and Chair of the National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council- provides an update on new and developing treatment products immediately following his attending the International Society on Thrombosis and Hemostasis (ISTH) Congress. Natalie leads a discussion on a recent CDC study that indicates opioid prescriptions are on the decline, Patrick initiates a game based on a new bleeding disorders online platform, and a community member shares her take on platelet disorders. All this and more on Episode 14 of The BloodStream Podcast!  Opioid Prescriptions Fall After 2010 Peak, C.D.C Report Finds https://www.nytimes.com/2017/07/06/health/opioid-painkillers-prescriptions-united-states.html Rare Platlet Disorders: https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders/types-of-bleeding-disorders/rare-platelet-disorders ISTH Congress 2017 Headlines: BioMarin and Spark: http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/    Idelvion: https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/   Emicizumab: https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors   Nuwiq: http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE Q&A with R&D chief of Bioverativ: https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline   Steven Pipe presents small molecule therapies: http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/   BloodFeed: https://www.bloodfeed.com Powering Through Podcast http://poweringthrough.org/podcast Ask The Expert Podcast http://bloodstreamexpert.com  

Today in FirstWord:

Today in FirstWord:

Today in FirstWord: